OraSure Technologies, Inc. announced that its Board of Directors has appointed Nancy Gagliano, MD to serve as interim Chief Executive Officer, effective April 1, 2022. Dr. Gagliano is not a candidate for the permanent CEO position. As previously announced, Stephen Tang Ph.D., President and CEO, will be the leaving the Company as of March 31, 2022.

The Board's search for a permanent CEO is actively underway. Dr. Gagliano, a member of the OraSure Board since November 2021, brings extensive leadership experience in the diagnostics and healthcare industries to this role, including recent service as an executive leader of the National Institute of Health's RADx Tech, a program focused on speeding the development, validation, and commercialization of innovative point-of-care and over-the-counter tests that can directly detect the COVID-19 virus.